---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "WDJlaNvMq676kJf4MN5UszIpGpYRc/+Op0Pf+tRRHLpBToqVfTicVGTCef6f9FokungYKtw26jNnoMVzPL/NTEyquuI0MsMwyn5QwQtn79Csdqp0fexDHuTh37m6tNudh2L15rvialahLeG6Zutm+0vIrcetIuUSLeSepE00bDWmLLYeraMT8yAL0+DfTH2WpoUg6XpiQHiWqESXm79D+lKrnwSe1DBUddBfFfDDNEmzO/9yUijes7PmOFmp8zVF9lk5zhDJZCjo+ogvfmjulHuWPQbCnnVrM6UVBCgG87JRRIN2zeqXbdmrfl6UgLpWEJUOcEqTb9/jpdHGRkxYsfYEinHIaiwMerclOQwtXHI=;YJBHA5IjL9neWLcyXO7WKw=="
---

